GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Net Margin %

Sumitomo Pharma Co (Sumitomo Pharma Co) Net Margin %

: -60.65% (As of Dec. 2023)
View and export this data going back to 2009. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Sumitomo Pharma Co's Net Income for the three months ended in Dec. 2023 was $-347 Mil. Sumitomo Pharma Co's Revenue for the three months ended in Dec. 2023 was $572 Mil. Therefore, Sumitomo Pharma Co's net margin for the quarter that ended in Dec. 2023 was -60.65%.

The historical rank and industry rank for Sumitomo Pharma Co's Net Margin % or its related term are showing as below:

DNPUF' s Net Margin % Range Over the Past 10 Years
Min: -52.59   Med: 8.06   Max: 11.45
Current: -52.59


DNPUF's Net Margin % is ranked worse than
80.2% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.765 vs DNPUF: -52.59

Sumitomo Pharma Co Net Margin % Historical Data

The historical data trend for Sumitomo Pharma Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.59 8.44 10.90 10.07 -13.41

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.96 -58.79 -51.34 -37.52 -60.65

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Net Margin % falls into.



Sumitomo Pharma Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sumitomo Pharma Co's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-557.456/4156.263
=-13.41 %

Sumitomo Pharma Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-347.038/572.199
=-60.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sumitomo Pharma Co  (OTCPK:DNPUF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sumitomo Pharma Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.